Sun Biomedical Limited (ASX:SBN) advises that the Chief Financial Officer, Mr Andrew
Paice, has resigned as an executive of the Company to take effect 29 February 2008.
Mr Paice’s resignation follows his recommendation to the Board that the Company
reduce its administrative overheads in Australia and focus a greater portion of its
assets in the operation of its US subsidiary, Sun Biomedical Laboratories Inc.
Mr. Paice will continue on the Board in a non executive capacity.
The Board of Sun Biomedical Limited thanks Mr. Paice for his contribution and service
as an executive of the Company
Add to My Watchlist
What is My Watchlist?